| Long Island Oral & Maxillofacial Surgery, Pc | |
|
134 Mineola Blvd. 3 Floor Mineola NY 11501 | |
| (516) 294-9696 | |
| (516) 294-3531 |
| Full Name | Long Island Oral & Maxillofacial Surgery, Pc |
|---|---|
| Speciality | Dentist |
| Location | 134 Mineola Blvd., Mineola, New York |
| Authorized Official Name and Position | Debra Mcquillan (MANAGER) |
| Authorized Official Contact | 5162949696 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Long Island Oral & Maxillofacial Surgery, Pc 134 Mineola Blvd. 3 Floor Mineola NY 11501 Ph: (516) 294-9696 | Long Island Oral & Maxillofacial Surgery, Pc 134 Mineola Blvd. 3 Floor Mineola NY 11501 Ph: (516) 294-9696 |
| NPI Number | 1912080417 |
|---|---|
| Provider Enumeration Date | 10/20/2006 |
| Last Update Date | 01/11/2008 |
| Medicare PECOS PAC ID | 2668362674 |
|---|---|
| Medicare Enrollment ID | O20040316000107 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912080417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | (New York) | Primary |
| Provider Name | Alex V Meneshian |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1396706412 PECOS PAC ID: 7012977721 Enrollment ID: I20041018000317 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | Victor L Nannini |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1750341368 PECOS PAC ID: 9436168754 Enrollment ID: I20060414000118 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | Ralph Cangiano |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1518927102 PECOS PAC ID: 8325057599 Enrollment ID: I20060417000423 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | Scott A Fauvell |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1265641732 PECOS PAC ID: 5294893210 Enrollment ID: I20081021000114 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | Lawrence Becker |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1235190430 PECOS PAC ID: 2365574936 Enrollment ID: I20100716000464 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | James G Choi |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1043638158 PECOS PAC ID: 5193143154 Enrollment ID: I20200908003377 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
| Provider Name | Luke C Soletic |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1164879581 PECOS PAC ID: 0749571560 Enrollment ID: I20220929000730 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
A new study, funded in part by a grant from the National Institutes of Health (NIH), shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival. Findings available in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, demonstrate that safety measures in place are working to protect patients.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
› Verified 6 days ago
Idi Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 319 Willis Ave, Mineola, NY 11501 Phone: 516-487-6453 | |
Dustin R. Solis Dds Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 192 Jericho Tpke, Mineola, NY 11501 Phone: 516-307-1050 Fax: 516-307-1052 | |
Winthrop Dental Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Old Country Rd, Suite 460, Mineola, NY 11501 Phone: 516-663-2752 Fax: 516-663-9373 | |
Andrew Sackserdds Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 140 Mineola Blvd, Mineola, NY 11501 Phone: 516-248-6018 | |
Winthrop University Center For Family Dental Medicine Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Old Country Rd, Suite 460, Mineola, NY 11501 Phone: 516-663-2752 Fax: 516-663-9373 | |
Eugene Simons Dds Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 331 Willis Ave, Mineola, NY 11501 Phone: 516-746-5050 Fax: 516-877-0311 | |
Pm Dental Care Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 Jericho Tpke, Mineola, NY 11501 Phone: 516-746-1111 Fax: 516-746-1114 |